Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema

BACKGROUND: Diabetic macular edema (DME) can be treated with different alternatives, among them Dexamethasone intravitreal implant 0.7 mg (DEX 0.7) has demonstrated that may improve both central macular thickness (CMT) and best corrected visual acuity (BCVA). This study aimed to evaluate the effect...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMC Ophthalmol
Main Authors: Castro-Navarro, Verónica, Cervera-Taulet, Enrique, Navarro-Palop, Catalina, Monferrer-Adsuara, Clara, Hernández-Bel, Laura, Montero-Hernández, Javier
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2019
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6330395/
https://ncbi.nlm.nih.gov/pubmed/30634940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-018-1022-9
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker